Every time through the AI Express, investors ask questions on the investor interaction platform: For Omi Keron, it is seen from the “Science” magazine that there is more than ten times the breakdown immunity to RNA, including inactivated vaccines, compared to Delta. With so many changes, participants are discussing whether it can still be called a new coronavirus. Please confirm the detection effect of Omi Keron as soon as possible, and it should become the mainstream strain in the follow-up. The initial reagents in South Africa were unable to detect Omi Keron. What should I do if the products produced earlier cannot be used?
Jiu’an Medical(002432.SZ) stated on the investor interaction platform on December 20 that, in principle, we believe that the company’s antigen detection products can detect the Omicron mutant strain. At present, the company is waiting for the arrival of the virus strain, and the laboratory is ready. Once the virus strain is obtained, we will conduct the test as soon as possible. If the Omicron mutant strain cannot be detected by any chance, we will adjust the relevant medical technology in due course.
(Source: Daily Economic News)
Article source: Daily Economic News
Editor in charge: 91
Original title: Jiu’an Medical: In principle, the company’s antigen detection products can detect Omicron mutant strains
Solemnly declare: The purpose of this information is to spread more information, and it has nothing to do with this stand.
report
Scan the QR code to follow
Oriental Wealth Official Website WeChat
.